1.48
                                            Schlusskurs vom Vortag:
              $1.49
            Offen:
              $1.59
            24-Stunden-Volumen:
                74,778
            Relative Volume:
              1.06
            Marktkapitalisierung:
                $18.50M
            Einnahmen:
              $11.41M
            Nettoeinkommen (Verlust:
              $-38.92M
            KGV:
              -0.3031
            EPS:
                -4.8828
            Netto-Cashflow:
                $-30.46M
            1W Leistung:
              -5.13%
            1M Leistung:
              -10.30%
            6M Leistung:
                -38.59%
            1J Leistung:
              -64.59%
            Curis Inc Stock (CRIS) Company Profile
Firmenname
                  
                      Curis Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      617-503-6500
                    
                Adresse
                  
                      128 SPRING STREET, LEXINGTON, MA
                    
                Vergleichen Sie CRIS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                CRIS
                            
                             
                        Curis Inc 
                           | 
                    1.48 | 18.62M | 11.41M | -38.92M | -30.46M | -4.8828 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Curis Inc Stock (CRIS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-05-19 | Fortgesetzt | H.C. Wainwright | Buy | 
| 2023-11-17 | Eingeleitet | Truist | Buy | 
| 2022-04-04 | Herabstufung | Raymond James | Outperform → Mkt Perform | 
| 2021-10-13 | Eingeleitet | Raymond James | Outperform | 
| 2021-03-25 | Eingeleitet | B. Riley Securities | Buy | 
| 2020-07-29 | Eingeleitet | Laidlaw | Buy | 
| 2020-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight | 
| 2017-10-24 | Eingeleitet | Guggenheim | Buy | 
| 2016-03-02 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy | 
| 2015-11-09 | Bestätigt | ROTH Capital | Buy | 
| 2015-08-11 | Eingeleitet | FBR Capital | Outperform | 
| 2015-01-22 | Bestätigt | Oppenheimer | Outperform | 
| 2015-01-21 | Bestätigt | ROTH Capital | Buy | 
| 2014-05-09 | Bestätigt | Oppenheimer | Outperform | 
| 2013-10-02 | Eingeleitet | Robert W. Baird | Outperform | 
| 2013-09-30 | Eingeleitet | Chardan Capital Markets | Buy | 
| 2012-11-14 | Eingeleitet | Stifel Nicolaus | Hold | 
| 2012-01-31 | Bestätigt | Brean Murray | Buy | 
| 2012-01-31 | Bestätigt | Summer Street Research | Buy | 
| 2011-12-09 | Eingeleitet | Oppenheimer | Outperform | 
| 2011-10-06 | Eingeleitet | Summer Street Research | Buy | 
| 2011-09-22 | Eingeleitet | MLV Capital | Buy | 
| 2011-03-21 | Bestätigt | Brean Murray | Buy | 
| 2010-02-26 | Bestätigt | Roth Capital | Buy | 
| 2010-01-07 | Eingeleitet | Roth Capital | Buy | 
                    Alle ansehen
                    
                  
                Curis Inc Aktie (CRIS) Neueste Nachrichten
What the charts say about Curis Inc. todayJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Will Curis Inc. (CUS0) stock gain from lower interest ratesQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
Can a trend reversal in Curis Inc. lead to recoveryEarnings Risk Report & Expert Approved Trade Ideas - newser.com
Applying Wyckoff theory to Curis Inc. stockJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - newser.com
Can Curis Inc. stock sustain revenue growthInflation Watch & Fast Exit and Entry Strategy Plans - newser.com
Can Curis Inc. (CUS0) stock sustain breakout momentumJuly 2025 Gainers & Community Supported Trade Ideas - newser.com
How Curis Inc. stock performs in high volatility markets2025 Technical Patterns & Free Community Consensus Stock Picks - newser.com
Is Curis Inc. (CUS0) stock a top hedge fund pick2025 Year in Review & Real-Time Volume Analysis Alerts - newser.com
Detecting support and resistance levels for Curis Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
How Curis Inc. stock responds to policy changesMarket Rally & High Conviction Buy Zone Alerts - newser.com
Is Curis Inc. stock attractive for income investorsJuly 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 - Barchart.com
Curis (NASDAQ: CRIS) to report Q3 2025 results; investor call at 4:30 p.m. ET - Stock Titan
What analysts say about Curis Inc stockREITs Market Trends & Free Fastest Return On Investment - earlytimes.in
Curis Stock Fell 7.7% in a Month, What Now? - Trefis
How buybacks impact Curis Inc. stock valueMarket Growth Report & Free Real-Time Volume Trigger Notifications - Fundação Cultural do Pará
Is Curis Inc. (CUS0) stock included in top ETFs2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Can Curis Inc. stock resist sector downturnsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Should You Invest in Ducon Infratechnologies Limited Before Its Next Earnings ReportSwing Trading Ideas & Get Alerts on Stocks Set to Skyrocket - earlytimes.in
Curis Inc.’s Promising Study on Emavusertib for AML and MDS: A Potential Game-Changer - TipRanks
Finanzdaten der Curis Inc-Aktie (CRIS)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):